Scarica l'app Stockscreener
0.7485
6.00%
0.0424
Dopo l'orario di chiusura:
.75
0.0015
+0.20%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Pds Biotechnology Corp Borsa (PDSB) Ultime notizie
Head and Neck Squamous Cell Carcinoma (HNSCC)Market Insights, Epidemiology, and Market Forecast - GlobeNewswire Inc.
Average basic shares outstanding of PDS Biotechnology Corp. – HAN:EU6 - TradingView
PDS Biotechnology Corporation (PDSB) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - cnn.com
PDS Biotechnology (NASDAQ: PDSB) Announces Phase 2 VERSATILE-002 Trial Results with 39.3-Month Median Survival - kalkinemedia.com
PDS Biotech reports 39.3-month survival data for HPV16 therapy By Investing.com - Investing.com Australia
PDS Biotech’s PDS0101 Shows 39.3-Month Median Survival in JAMA Oncology Publication - Minichart
PDS Biotech reports 39.3-month survival data for HPV16 therapy - Investing.com
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology - The Manila Times
A head-and-neck cancer trial reported 39.3 months of median survival - Stock Titan
Patrick Soon-Shiong Secures Board Seat at PDS Biotechnology with 19.9% Stake - TradingView
PDS Biotechnology gets 19.9% Nant Capital stake | PDSB SEC FilingForm SCHEDULE 13D - Stock Titan
PDS Biotechnology updates corporate presentation highlighting PDS0301 clinical data and financing - TradingView
Patrick Soon-Shiong backs PDS Biotechnology (NASDAQ: PDSB) as cancer drugs move toward Phase 3 - Stock Titan
PDS Biotechnology Corporation (PDSB) Options ChainYahoo Finance - Yahoo! Finance Canada
PDS Biotechnology (PDSB) Stock Fair Value Moves Lower After Analyst Cuts And Financing Scrutiny - Yahoo Finance
PullBack Stocks PDSB, PRSO, IGC, RETO: Who Breaks First? - FinancialContent
PDS Biotech Stock Surges Tuesday: What's Driving the Action? - Benzinga
PDS Biotechnology jumps as investors react to PIPE closing and Patrick Soon-Shiong tie-up - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PDSB Financing Adds 40 Million Share Equivalents Before Warrants - TechStock²
PDS Biotechnology Closes $11.3 Million Initial PIPE Tranche Led by Nant Capital - Minichart
PDS Biotechnology Retires Debt and Secures New Financing - TipRanks
PDS Biotechnology Retires Yorkville $6M Note Early With $4.6M Redemption - TradingView
PDS Biotech Raises $11.3 Million in Initial PIPE Led by Patrick Soon-Shiong - citybiz
PDS Biotechnology Raises $11.3 Million in Initial Closing of PIPE Led by Nant Capital; Dr. Soon-Shiong Joins Board - Quiver Quantitative
Weekly Recap: Up to $22.55M PIPE and HC Wainwright cuts price target to $5 - TradingView
PDS Biotechnology Market Sentiment - Benzinga España
Most Active Stocks on September 8: PDS Biotech, Green Circle, Mobix Labs, Intel and Nokia Lead Volume - ChartMill
Curious about the most active stocks on Tuesday? - ChartMill
PDS Biotech soars as it announces up to $22.55 million financing - thepharmaletter.com
PDS Biotech Jumps as Soon-Shiong-Backed Financing Eases Funding Pressure - Quiver Quantitative
PDS Biotech raises up to USD 22.55m to advance IL-12 immunotherapy toward Phase III in CRC - AllSci
Dow Tumbles 450 Points; US Small Business Sentiment Declines In August - Benzinga
PDS Biotechnology Announces PIPE Financing and Strategic Alignment - TipRanks
PDS Biotech raises up to $22.55M led by Nant Capital - Investing.com Canada
Phase 3 trial plan could unlock $11M more for PDS Biotechnology (NASDAQ: PDSB) - Stock Titan
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks - marketscreener.com
80% survived at least two years in a 22-patient trial of PDS Biotech's cancer treatment - Stock Titan
PDS Biotechnology’s Phase 3 Head and Neck Cancer Trial Termination: What It Means for Investors - TipRanks
PDS Biotech’s Lender Gets 100% of New Non-ATM Equity Cash - TechStock²
PDSB News | PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) - ChartMill
PDS Biotechnology Amends $6 Million Promissory Note, Tightening Repayment With YA II PN - TradingView
PDS Biotechnology (Nasdaq: PDSB) changes terms on a $6M loan - Stock Titan
Stephan Toutain removed as COO at PDS Biotechnology - TradingView
PDS Biotechnology (PDSB) to shed 36% of staff and part ways with COO - Stock Titan
PDS Biotechnology Corp (NASDAQ: PDSB) Share Price, PDSB Stock News, PDSB Share Price & Updates - Kalkine
Form 8K PDS Biotechnology Corp For: 19 August By Investing.com - Investing.com Nigeria
PDS Biotechnology announces CFO resignation and interim appointments - Investing.com
PDS Biotechnology CFO Lars Boesgaard to Resign; Janetta Trochimiuk and Frank Bedu-Addo Appointed Interim Officers - TradingView
PDS Biotechnology (NASDAQ: PDSB) CEO takes interim finance role as CFO departs - Stock Titan
Weekly Recap: PDS0301 Phase 2 results and Q2 adjusted loss $0.18 - TradingView
PDS Biotechnology shareholders approve charter amendment and director elections - Investing.com
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):